Enimmune corporation 6564.TWO Stock
Enimmune corporation Price Chart
Enimmune corporation 6564.TWO Financial and Trading Overview
| Enimmune corporation stock price | 33 TWD |
| Previous Close | 49.6 TWD |
| Open | 50.1 TWD |
| Bid | 49.8 TWD x 0 |
| Ask | 50.3 TWD x 0 |
| Day's Range | 49.65 - 50.4 TWD |
| 52 Week Range | 34.3 - 72.6 TWD |
| Volume | 62.58K TWD |
| Avg. Volume | 135.69K TWD |
| Market Cap | 3.32B TWD |
| Beta (5Y Monthly) | 0.463041 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.54 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6564.TWO Valuation Measures
| Enterprise Value | 2.93B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 17.601145 |
| Price/Book (mrq) | 6.0898986 |
| Enterprise Value/Revenue | 15.536 |
| Enterprise Value/EBITDA | -10.521 |
Trading Information
Enimmune corporation Stock Price History
| Beta (5Y Monthly) | 0.463041 |
| 52-Week Change | 25.94% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 72.6 TWD |
| 52 Week Low | 34.3 TWD |
| 50-Day Moving Average | 51.4 TWD |
| 200-Day Moving Average | 53.41 TWD |
6564.TWO Share Statistics
| Avg. Volume (3 month) | 135.69K TWD |
| Avg. Daily Volume (10-Days) | 125.2K TWD |
| Shares Outstanding | 65.8M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -131.60% |
| Operating Margin (ttm) | -152.013% |
| Gross Margin | 11.06% |
| EBITDA Margin | -147.66% |
Management Effectiveness
| Return on Assets (ttm) | -25.84% |
| Return on Equity (ttm) | -43.23% |
Income Statement
| Revenue (ttm) | 188.42M TWD |
| Revenue Per Share (ttm) | 2.95 TWD |
| Quarterly Revenue Growth (yoy) | 62.89% |
| Gross Profit (ttm) | N/A |
| EBITDA | -278220992 TWD |
| Net Income Avi to Common (ttm) | -247963008 TWD |
| Diluted EPS (ttm) | -3.84 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 487.07M TWD |
| Total Cash Per Share (mrq) | 7.4 TWD |
| Total Debt (mrq) | 29.66M TWD |
| Total Debt/Equity (mrq) | 4.46 TWD |
| Current Ratio (mrq) | 6.04 |
| Book Value Per Share (mrq) | 8.276 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -200636000 TWD |
| Levered Free Cash Flow (ttm) | -127895872 TWD |
Profile of Enimmune corporation
| Country | Taiwan |
| State | N/A |
| City | Taichung City |
| Address | No. 3, Section 1 |
| ZIP | N/A |
| Phone | 886 4 2536 0925 |
| Website | https://www.enimmune.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Enimmune corporation operates as a biopharmaceutical Research and development, and marketing company in Taiwan. Its products include Tuberculin PPD RT23 SSI, an approved drug for tuberculin test to determine whether the patient is infected with tuberculosis. The company is also involved in the development of vaccines to prevent various infectious diseases, such as enterovirus, pneumonia, norovirus, dengue fever virus, Middle East respiratory syndrome coronavirus, etc. Enimmune corporation was founded in 2014 and is based in Taichung City, Taiwan.
Q&A For Enimmune corporation Stock
What is a current 6564.TWO stock price?
Enimmune corporation 6564.TWO stock price today per share is 33 TWD.
How to purchase Enimmune corporation stock?
You can buy 6564.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Enimmune corporation?
The stock symbol or ticker of Enimmune corporation is 6564.TWO.
Which industry does the Enimmune corporation company belong to?
The Enimmune corporation industry is Biotechnology.
How many shares does Enimmune corporation have in circulation?
The max supply of Enimmune corporation shares is 65.91M.
What is Enimmune corporation Price to Earnings Ratio (PE Ratio)?
Enimmune corporation PE Ratio is now.
What was Enimmune corporation earnings per share over the trailing 12 months (TTM)?
Enimmune corporation EPS is -2.54 TWD over the trailing 12 months.
Which sector does the Enimmune corporation company belong to?
The Enimmune corporation sector is Healthcare.